The page is the record's research on the issuer — no analyst, no rating, no view. # QIAGEN N.V. (NYSE: QGEN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is QIAGEN N.V., listed on NYSE under ticker QGEN, ISIN USN724821566. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-P7). The security type is Non-operating entity type (other); the segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances); the jurisdiction is Netherlands. The issuer is listed, not halted. ## The disclosure read The record holds 25 filings in the twelve months to 2026-11-08, across 17 filing days. By type: 13 results, 9 regulatory filings, 2 takeover, 1 halt or suspension. The median gap between filing days is 20.5 days, against an exchange median of 6.0 days and a sector median of 5.5 days. The latest filing is dated 2026-11-06 and is of type results, 2 days before the record date. The exchange median latency is 4.0 days and the sector median latency is 4.0 days. The exchange median filing count is 64.0 and the sector median is 65.5; the issuer's 25 filings are below both. ## Auditor The auditor of record is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two delisting lines, dated 2026-01-08 and 2026-01-09. It holds no listing or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001015820.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/QGEN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/QGEN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/QGEN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp